Arun Goel, MD
Assistant Professor of Clinical Radiation Oncology
Site Chief, Genitourinary Radiation Oncology, Department of Radiation Oncology, University of Pennsylvania School of Medicine
Department: Radiation Oncology
Contact information
3400 Civic Center Blvd.
Perelman Center for Advanced Medicine
Philadelphia, PA 19104
Perelman Center for Advanced Medicine
Philadelphia, PA 19104
Education:
BA (Biology Modified with Chemistry)
Dartmouth College, 2009.
MD (Doctorate of Medicine)
Drexel University College of Medicine, 2014.
Permanent linkBA (Biology Modified with Chemistry)
Dartmouth College, 2009.
MD (Doctorate of Medicine)
Drexel University College of Medicine, 2014.
Description of Clinical Expertise
HDR BrachytherapyHDR Prostate Brachytherapy
HDR Gynecologic Brachytherapy
Prostate SBRT
Ultrasound-based HDR Brachytherapy
Renal SBRT
Selected Publications
Abigail Pepin, Arun Goel, Neha Vapiwala: The Use of Particle Therapy in Prostate Cancer. Seminars in Radiation Oncology 35(3): 353-361, July 2025.Abigail Pepin*, Casey Hollawell*, Scott Appel, Jonathan Fu, Karen Tang, Joshua Bryer, Amanda Munter, Nishant Shah, Kristine Kim, Steve Feigenberg, Jeffrey Bradley, William Levin, Russell Maxwell, Alexander Lin, Karishma Khullar, James Metz, John Plastaras, Arun Goel: Natural Language Processing Chatbot and Continuous Activity Monitoring in a Phase II Randomized Trial: Impact on Hospitalizations and Quality of Life. Submitted to ASTRO Late breaking Abstracts 2025.
Hsu M, Shan X, Zhang R, Berlin E, Goel A, Agarwal M, Wong YN, Christodouleas JP, Vaughn DJ, Narayan V, Takvorian SU, Vapiwala N, Pantel AR, Haas NB: Prostate Cancer Recurrence: Examining the Role of Salvage Radiotherapy Field and Risk Factors for Regional Disease Recurrence Captured on 18F-DCFPyL PET/CT. Clin Genitourin Cancer 22(4): 102108, Aug 2024.
Shah NK, Kim KN, Grewal A, Wang X, Ben-Josef E, Plastaras JP, Metz JM, Goel A, Taunk NK, Shabason JE, Lukens JN, Berman AT, Wojcieszynski AP: Activity Monitoring for Toxicity Detection and Management in Patients Undergoing Chemoradiation for Gastrointestinal Malignancies. JCO Oncology Practice 18(6): e896-e906, Jun 2022.
Manuj Agarwal MD, Christopher Wright MD, Shweta Manjunath MD, Arun Goel MD: Dose Escalation for High-Risk Prostate Cancer: Brachytherapy versus Stereotactic Body Radiotherapy Boost. ABS BrachyBlast NewsLetter Feb 2022.
Gorovets D, Hopkins M, Kollmeier M, Moore A, Goel A, Shasha D, Brennan V, McBride S, Cohen G, Damato AL, Zelefsky MJ: Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer. Brachytherapy 20(6): 1099-1106, Nov-Dec 2021.
Arun Goel MD, Chi-Mei Liu Ph.D, Praneet Kaur, Michael L. Wong MD, Lawrence M. Scala MD: Genitourinary Toxicity in patients with Intermediate and High Risk Prostate Cancer managed with Hypofractionated Radiation and HDR Brachytherapy Boost. American Society for Radiation Oncology Annual Meeting, San Antonio, TX 2018 Notes: e-poster
Huang AJ, Huang KE, Kumar RJ, Goel A, Harandi NK, Birer SR, Rounsaville MC, Lee JW, Abendroth R: Two-Fraction Radiosurgery (9Gy x 2) is an effective and safe option in the Modern Era of CNS-Penetrating Systemic Therapies Radiological Society of North America Annual Meeting, Chicago, IL 2018 Notes: oral.
Huang AJ, Huang KE, Kumar RJ, Goel A, Harandi NK, Rounsaville MC, Abendroth RE, Lee JW: Dose-Reduced Stereotactic Radiosurgery for Brain Metastases in the Era of CNS-Penetrating Systemic Therapies American Society for Radiation Oncology Annual Meeting, San Antonio, TX 2018 Notes: poster.
Harandi NK, Goel A, Huang AJ, Huang KE, Abendroth RA, Lee JW, Kashani-Sabet M, Kim KB: Outcomes for advanced melanoma with brain metastases treated with stereotactic radiosurgery (SRS) with and without PDL1 therapy American Society for Radiation Oncology Annual Meeting, San Antonio, TX 2018 Notes: poster.